All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Referral
Back
Contact us about this page
Key messages
Toggle Pages
Print this page
Important information on NHS eReferrals release 13.9
Radiology Waiting Times - RDU Northern locality
ADHD and Autism FAQ
Community Access to Neutralising Monoclonal Antibodies (nMAB) and Oral Antivirals for Covid-19 Treatment
Radiology Waiting Times - RDU Eastern locality
Advice and Referral teledermatology service for non-2WW referrals - RDU Eastern
Teledermatology for Advice & Guidance and Referrals
Waiting Times for Routine Care
Diabetic Eye Screening Programme (DESP)
Hydroxychloroquine Retinopathy Monitoring
Removal of flexible sigmoidoscopy direct access to GPs at NDHT
Expediting Referrals – how to communicate with Secondary Care
Cancer Education Webinar Videos by the Peninsula Cancer Alliance
Gender identity services covering Devon
Devon patient choice statement for seeking an alternative provider when the 18-week referral to treatment (RTT) is breached
Devon patient choice statement
GP Guidance: Using the Consultant Connect App to take secure clinical images using your smartphone
Royal Devon University Healthcare NHSFT - Advice & Guidance
Safeguarding App
Key Messages Archive
Contact us about this page
Hydroxychloroquine Retinopathy Monitoring
A new community service is being commissioned to monitor patients on HCQ/chloroquine. Please do not refer any patients to the Eye Hospitals in the meantime unless the optometrist has diagnosed definite toxicity. When the service is up and running the provider will be in contact to make sure they have a complete record of all the patients needing monitoring and when.
More details about the arrangements are in the letter here.
Publication date: March 2022
